Subscribe

News
Academy
Multimedia
Conferences
Publications
Partner Perspectives
Resources
Subscribe

Michael B. Harlin

Partner at Neal Gerber Eisenberg, specializing in life sciences intellectual property.

Articles by Michael B. Harlin

Intellectual Property Considerations for Drug Discovery Via Artificial Intelligence

ByMichael B. Harlin

July 26th 2022

Latest Updated Articles

Trending on PharmExec

FDA to Take Action Against Mass-Marketing of Illegal Copycat Drugs: Report

Everything to Know About TrumpRx in 2026

Novo Nordisk Launches First Super Bowl Commercial for Wegovy Pill

Pharmaceutical Executive Daily: The Launch of TrumpRx